Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Citryll B V is currently addressing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution is handled by 1 distinct examiner within 1 distinct art unit, indicating a consolidated examination process for the company's active filings. This level of consolidation is common for companies with a specific therapeutic focus, as it allows the USPTO to maintain consistency in how the technology is reviewed. A consolidated approach in the Biotechnology & Pharmaceuticals sector can help in maintaining a clear and consistent claim construction against a single set of prior art.
MOSELEY II, NELSON B is the busiest examiner for the company, managing the 1 pending office action. This individual is responsible for the only active office action currently facing the company's portfolio. Because there is only 1 distinct examiner involved, the company can focus its efforts on a single channel of communication. The outcome of the 1 pending office action under MOSELEY II, NELSON B will be a significant milestone for the company's Biotechnology & Pharmaceuticals portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOSELEY II, NELSON B | 1 | 68.0% | +41.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18289559 | INHIBITION OF EOSINOPHILIC TRAPS | MOSELEY II, NELSON B | — |
| Art Unit | Apps |
|---|---|
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18289559 | INHIBITION OF EOSINOPHILIC TRAPS | MOSELEY II, NELSON B | 1642 | §103§112DP | Non-Final OA | — | Pending | Nov 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial